Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention–induced myocardial injury

BACKGROUND: Trimetazidine (TMZ) is a metabolic modulator that shifts substrate utilization from fatty acid to carbohydrates, thereby, increasing myocardial glucose oxidation and improving myocardial ischemia. We evaluated whether TMZ is effective in reducing myocardial injury after percutaneous coro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazmi, Danish H., Kapoor, Aditya, Sinha, Archana, Ambesh, Paurush, Kashyap, Shiridhar, Khanna, Roopali, Kumar, Sudeep, Garg, Naveen, Tewari, Satyendra, Goel, Pravin K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Interventional Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309873/
https://www.ncbi.nlm.nih.gov/pubmed/30595291
http://dx.doi.org/10.1016/j.ihj.2018.10.415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309873/
https://www.ncbi.nlm.nih.gov/pubmed/30595291
http://dx.doi.org/10.1016/j.ihj.2018.10.415

Ejemplares similares